• Vanilla_PuddinFudge@infosec.pub
    link
    fedilink
    English
    arrow-up
    11
    ·
    29 days ago

    Here, take this pill

    “Will it cure me?”

    You won’t have cancer anymore, that’s for sure!

    “Welp, down the hatch!”

    dies

  • MajinBlayze@lemmy.world
    link
    fedilink
    English
    arrow-up
    4
    ·
    edit-2
    30 days ago

    There really needs to be a rhetorical distinction between regular machine learning and something like an llm.

    I think people read this (or just the headline) and assume this is just asking grok “what interactions will my new drug flavocane have?” Where these are likely large models built on the mountains of data we have from existing drug trials

    • holomorphic@lemmy.world
      link
      fedilink
      English
      arrow-up
      1
      ·
      edit-2
      29 days ago

      Those models will almost certainly be essentially the same transformer architecture as any of the llms use; simply because they beat most other architectures in almost any field people have tried them. An llm is, after all, just classifier with an unusually large set of classes (all possible tokens) which gets applied repeatedly

      • FatCrab@slrpnk.net
        link
        fedilink
        English
        arrow-up
        3
        ·
        29 days ago

        A quick search turns up that alpha fold 3, what they are using for this, is a diffusion architecture, not a transformer. It works more the image generators than the GPT text generators. It isn’t really the same as “the LLMs”.

  • TheFogan@programming.dev
    link
    fedilink
    English
    arrow-up
    2
    arrow-down
    1
    ·
    1 month ago

    I mean I hate AI in general… but to be honest… assuming no one is stupid enough to bypass the trials etc… I’m all for it, 90% of these problems already exist in the existing system, who owns it, can a corporation charge us to death.

    The only reasonable fear is, if they come out with more than they can develop trials for, and they lobby to lower standards in trials. Even that honestly is a more acceptable risk in the context of terminal diseases/severe cancers.

  • rhombus@sh.itjust.works
    link
    fedilink
    English
    arrow-up
    1
    ·
    30 days ago

    I’m sure all the savings from accelerated/cheaper R&D will be passed on to the consumer…right?

  • altphoto@lemmy.today
    link
    fedilink
    English
    arrow-up
    1
    ·
    29 days ago

    Okay here we go guys! Drink up!

    Feel anything yet? Let’s try another… Hold up! Wow, I can see 360!

    Dude! Gnarly! You got eyes in the back of y…dude I can see 360 too!

    Nah, I only see 360 pills. Where do you see the other two?

    Holy wakamoly! You got 360 eye balls!

    Experiment 00000000001… Failure…

    • altphoto@lemmy.today
      link
      fedilink
      English
      arrow-up
      1
      ·
      29 days ago

      Did the machine test its first human drug yet?

      Yes! LSD!..didn’t work.

      Well Dr. Chich what will we try next?

      We? Or the machine?